Markham Family Award on Liver Diseases & Liver Transplantation
Goals of the Markham Family Award
- To improve patient care outcomes through new scientific knowledge
- To develop new diagnostics, novel treatments, and discover biomarkers of disease, with the aim to offer earlier treatment with enhanced therapies, delay or prevent the need for liver transplantation, and optimize outcomes for liver transplant recipients.
Previous Recipients
2024
Jonathan Merola, MD, PhD
“Autotransplantation of Gene-Corrected iPSC-Derived Hepatocyte Organoids for Monogenetic Liver Disease”
2023
Amy E. Taylor, MD
“Patient-Centered Evaluation of Outcomes in Autoimmune Hepatitis”
Alexander Bondoc, MD and Kathleen M. Campbell, MD
"Starzl Network for Excellence in Pediatric Liver Transplantation/SNEPT"
2022
Anna L. Peters, MD, PhD
"Pediatric Liver Transplant Biorepository"
2021
YunZu Michele Wang, MD and Kasiani C. Myers, MD
"Liver Pathology in Telomere Biology Disorders"
2019
Akihiro Asai, MD, PhD
"Functional analysis of genetic variants in ATP7B discovered in a patient with neonatal acute liver failure”
Anna L. Peters, MD, PhD
“Molecular crosstalk between T cells and B cells in pediatric liver transplant rejection”
2018
Alexander Bondoc, MD
2015
Senad Divanovic, PhD
"Pathogenic Potential of Th17 Axis in NAFLD Severity"
2014
Jaimie Nathan, MD
"Intestinal Microbiota in Children with Chronic Liver Disease"
2013
Alexander Miethke, MD and Stacey Huppert, PhD
"FIC1 Disease Modeling Using Induced Pluripotent Stem Cells"
